Metastatic Colorectal Adenocarcinoma

Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 1 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
1 program
1
Stereotactic Ablative RadiotherapyPhase 31 trial
Active Trials
NCT05673148Recruiting364Est. Aug 2032
TheraBionic
TheraBionicGermany - Ettlingen
1 program
1
FruquintinibPhase 2Small Molecule1 trial
Active Trials
NCT07130903RecruitingEst. Apr 2030

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
2029
2030
2031
Alliance PharmaceuticalsStereotactic Ablative Radiotherapy
TheraBionicFruquintinib

Clinical Trials (2)

Total enrollment: 364 patients across 2 trials

NCT05673148Alliance PharmaceuticalsStereotactic Ablative Radiotherapy

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Start: Oct 2023Est. completion: Aug 2032364 patients
Phase 3Recruiting
NCT07130903TheraBionicFruquintinib

Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer

Start: Sep 2025Est. completion: Apr 2030
Phase 2Recruiting

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
5m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
5m ago

Office Administrator

SystImmune
5m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
16m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
19m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
19m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 actively recruiting trials targeting 364 patients
Small Molecule is the dominant modality (100% of programs)
2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)